What MEDDIC Actually Stands For
MEDDIC is a qualification framework, not a pitch framework. It stands for Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain and Champion, and its job is to answer one question before a rep spends another month on an opportunity: is this deal real, or is it a series of pleasant conversations that will never reach a signature? The methodology is associated with the enterprise software company PTC in the 1990s and was later carried into force management and sales enablement programmes across the software industry. Its origin in complex, multi-stakeholder software sales explains why it feels heavy for a transactional deal and exactly right for one involving procurement, legal and three layers of internal sign off.
Each of the six letters forces a rep to go and find a fact rather than infer one. That distinction matters more than the acronym itself. A rep can believe a prospect is serious. MEDDIC asks them to name the person who controls the budget, describe the number the prospect is trying to move, and produce evidence that someone inside the account will argue for the deal when the rep is not in the room. Belief does not survive a pipeline review; named facts do.
Why MEDDIC Exists: The Problem With Ungated Pipeline
Pipeline built on stage duration and rep confidence alone has a structural flaw: nothing in the data forces the confidence to be correct. A deal can sit in “Proposal Sent” for six weeks looking identical to a deal that will close and a deal that has gone cold, because the CRM stage only records what the rep did, not what the buyer has confirmed. Forecast reviews built on that kind of pipeline tend to drift toward optimism, because reps are rewarded for showing activity and penalised for showing doubt, and managers rarely have the buyer-side facts needed to challenge a confident rep in the room.
MEDDIC closes that gap by attaching qualification to specific, checkable claims: a named economic buyer, a stated metric, a champion who has done something concrete on your behalf. A sales leader reviewing a MEDDIC-qualified deal is not asking “how do you feel about this,” they are asking “who told you that” and “when did they last confirm it.” That second question is the entire point of the framework, and it is why RevOps teams that build MEDDIC into the CRM properly end up with forecasts that survive contact with a quarter end.
Metrics: Attaching a Number to the Deal
The metric in MEDDIC is not your ROI calculator output, it is the number the customer already tracks and cares about: cost per shipment, hours spent on manual reconciliation, error rate on a monthly report, headcount tied up in a process you would automate. The mechanism is sequencing: ask for the customer’s own number before presenting your projected saving. A prospect who supplies their own figure has effectively built your business case for you and is far more likely to repeat it internally than a number you handed them.
The common failure mode is a rep who skips straight to a vendor-built ROI slide. The number looks credible in the room and is forgotten the moment the rep leaves, because it was never adopted as the customer’s own reasoning. If a prospect cannot state, in their own words, what improving by your solution is worth to them, the metric has not actually been established, no matter how polished the accompanying slide is.
Economic Buyer: Finding Who Actually Signs
The economic buyer is the person with authority to release budget, not the most senior person you have spoken to and not the person who is friendliest to you. In a small business that might be the founder. In a larger organisation it could be a departmental director with a defined spending ceiling, or a shared decision between finance and the sponsoring function. The authority can be delegated downward for the evaluation and pulled back upward for the signature, and confusing the two is one of the most common reasons a “verbal yes” stalls.
A direct test: ask your main contact who has previously said no to a similar purchase, and why. If they cannot answer, they are probably not the economic buyer, because someone with real budget authority always has a story about a deal they killed. Get to that person, even briefly, before the proposal stage. A rep who has never spoken to the actual budget holder is negotiating with an intermediary and will discover the real objections only after the paperwork is already moving.
Decision Criteria: How They Will Judge the Options
Buyers typically judge a purchase against three separate sets of criteria: technical (does it do what we need), business (what does it cost to implement, run and exit), and relationship (do we trust this vendor to still exist and support us in three years). Sales teams that only track the technical criteria, because that is what appears in an RFP or feature comparison, routinely lose deals they thought they were winning, because the business or relationship criteria eliminated them at a stage the rep never saw.
Where possible, ask to see the evaluation scorecard the buying committee is actually using. If no formal scorecard exists yet, that is an opening rather than a gap: a rep who helps shape the criteria before they are frozen has a structural advantage over a competitor reacting to a document handed to them later. Reps should treat “what does a great vendor look like to you” as a required discovery question, not an optional one.
Decision Process: Mapping the Steps to Signature
Decision process is the sequence of remaining steps between now and a signed contract, ideally with a named person and an approximate date against each one. This is where a deal that looks close on the surface can actually be months away, because a verbal agreement from the economic buyer still has to pass through procurement, security review, legal redlines and, in regulated sectors, an information-governance sign off that nobody mentioned in the first three meetings.
The failure mode here is treating a positive signal from the economic buyer as equivalent to a closed deal. It is not; it is permission to enter the next set of gates. A rep who cannot list the remaining approval steps by name has not mapped the decision process, they have simply had an encouraging conversation. Ask directly: “after you say yes, what happens next, and who owns that step?”
Identify Pain: Turning a Problem Into a Reason to Act
Pain in MEDDIC is not a generic list of frustrations, it is the specific problem that will make someone act now rather than defer the decision to next year. Crucially, the pain is rarely the same for every stakeholder. The end user’s pain might be hours lost to manual data entry; the economic buyer’s pain might be an inaccurate board-level forecast built on that same bad data. Both are real, and a rep who only articulates the user-level pain will struggle to justify the spend to the person who actually signs.
Multi-threading the pain, finding and confirming a distinct version of it with each stakeholder group, is what separates a deal built on one enthusiastic contact from one that survives that contact changing role or leaving the business. If every stakeholder describes the same pain in the same words, that is usually a sign the rep has only spoken to one part of the account.
Champion: Why One Internal Advocate Is Not Enough
A champion is an internal contact with both the will and the political capital to sell on your behalf when you are not in the room. A friendly contact who shares information but never puts their own credibility on the line is a coach, useful but not sufficient. The distinction matters because deals that rely entirely on a coach tend to stall the moment real internal resistance appears, since nobody on the inside is prepared to spend capital defending the purchase.
Test a suspected champion by asking them to do something that costs them something: introduce you to the economic buyer, share the internal budget range, or argue your case in a meeting you are not invited to. A genuine champion will do it, or at least try. A single champion is also a single point of failure; if that person changes role, is promoted out of the buying committee, or leaves the organisation mid-cycle, the deal can lose its internal advocate overnight, which is why experienced teams try to develop a second, quieter champion in parallel.
MEDDIC vs MEDDPICC: When to Add Competition and Paper Process
MEDDPICC adds two elements to the original six: Competition and Paper Process. Competition tracks who else is in the evaluation and how your offer compares against their specific criteria, not just your general strengths. Paper Process tracks the legal, security and procurement steps still required after a verbal agreement, and it is frequently the longest and least visible part of a complex sale. A deal can be fully qualified on the original six elements and still take months longer than expected because nobody mapped the paper process until after the “yes.”
Whether the extra two elements are worth the additional CRM fields and admin time depends on deal complexity. A sale into a large, regulated organisation, where an information-governance or security review sits between agreement and signature, benefits from tracking Paper Process explicitly. A short, single-decision-maker sale rarely needs it, and adding it anyway just gives reps more fields to fill in without changing the outcome of the deal.
Building MEDDIC Into Your CRM Instead of a Spreadsheet
MEDDIC only changes forecast accuracy if it lives inside the system reps actually work in, rather than a spreadsheet nobody updates after week two. The practical build is a set of custom fields on the opportunity object, one per MEDDIC element, paired with validation rules that block progression to the next stage if a required field is empty. Salesforce and HubSpot both support this pattern through opportunity or deal properties and stage-based validation, documented at help.salesforce.com and developers.hubspot.com respectively. A “Champion Confirmed” checkbox that a rep cannot tick without a linked contact record and a note field does far more for forecast honesty than a free-text notes box that reps skip under deadline pressure.
Reporting is the other half of the build: a pipeline dashboard segmented by MEDDIC completeness, showing which open deals are missing an economic buyer or a champion, gives sales managers a prioritised coaching list instead of a vague sense that “some deals feel weaker.” Bear in mind that the fields you are populating will often include names, roles and internal budget information about individuals at the prospect’s organisation, which counts as personal data under UK data protection law; RevOps should apply the same access and retention discipline to CRM opportunity records as to any other customer data store, per the guidance at ico.org.uk.
Where MEDDIC Breaks Down
MEDDIC assumes a single, identifiable economic buyer, and that assumption does not hold for every deal. In organisations that buy by consensus, where a committee reaches a shared decision with no individual signing authority, forcing a rep to name one economic buyer can produce a fabricated answer rather than a useful one. In that situation, the more honest adaptation is to track the buying group as a set and record where consensus is forming and where it is stuck, rather than pretending a single name exists.
A separate and more common failure is compliance theatre: reps learn which fields a validation rule requires and fill them in to pass the gate, without doing the underlying qualification work. A “Champion” field populated the same day as a stage change, or an economic buyer name that never appears again in call notes or email threads, is a reliable sign the field was completed to satisfy the CRM rather than to reflect a real conversation. RevOps can catch this by cross-referencing MEDDIC field completion dates against actual meeting or email activity on the record, not by trusting the field value on its own.
Rolling MEDDIC Out Without Killing Rep Adoption
Mandating all six fields from the first pipeline stage tends to produce exactly the compliance theatre described above, because reps have no real information yet and fill the fields with guesses just to move the deal forward. A better sequence ties field requirements to stage: Metrics and Pain expected early, Economic Buyer and Decision Criteria by the middle stages, Decision Process and Champion confirmed before a deal can be marked as forecast-committed. This mirrors how the information genuinely becomes available during a real sales cycle.
The rollout succeeds or fails in the deal review meeting, not in the CRM configuration. If a sales manager checks that a field is populated and moves on, reps learn that the letter of the field matters more than the substance. If the manager instead asks “who told you that, and when,” reps learn that the qualification itself is being checked, and the fields start to reflect reality rather than a rep’s optimism about a deal that has not yet earned it.
Related Reading
Frequently Asked Questions
Is MEDDIC only useful for enterprise sales?
No, but the value is closely tied to deal complexity. MEDDIC earns its overhead when several stakeholders are involved and the deal is genuinely at risk of stalling in procurement. For simple, single-decision-maker, short-cycle deals, running the full checklist can slow reps down for little return.
What is the difference between MEDDIC and MEDDPICC?
MEDDPICC adds Competition and Paper Process to the original six elements. Competition tracks who else the buyer is evaluating and how you compare on their criteria. Paper process tracks the legal, security and procurement steps still needed after a verbal yes, which is often the longest and least visible part of the deal.
How do I stop reps filling in MEDDIC fields without doing the actual qualification?
Treat the CRM fields as evidence of a conversation, not the conversation itself. In deal reviews, ask reps to state who told them the Economic Buyer’s name or what the customer said their Metric was, rather than just checking that the field is populated. Fields completed in a single sitting right before a stage change are a common sign of compliance theatre.
Who should own the MEDDIC fields in the CRM, sales or RevOps?
RevOps typically owns the schema, the validation rules and the reporting, while sales management owns the coaching that makes the data honest. If RevOps builds the fields without sales leadership reinforcing them in deal reviews, the fields decay into guesswork within a quarter.
How do I tell a real champion from someone who is just being friendly?
Ask them to do something that costs them political capital, such as introducing you to the Economic Buyer or sharing internal budget information. A coach will hand you information but will not put their own credibility on the line inside the business; a champion will.
For more on this, see more RevOps strategy posts, including SaaS Growth: From WhatsApp MVP to Scalable Revenue, Loop Marketing & AI-Powered CRM: Replacing Funnels for SaaS Growth, and RevOps Strategies for Commercial Cleaning SaaS Sales.
Leave a Reply